Villere ST Denis J & Co. LLC Raises Position in Option Care Health, Inc. (NASDAQ:OPCH)

Villere ST Denis J & Co. LLC boosted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 18.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,344,608 shares of the company’s stock after buying an additional 209,502 shares during the period. Option Care Health makes up 2.8% of Villere ST Denis J & Co. LLC’s investment portfolio, making the stock its 11th biggest holding. Villere ST Denis J & Co. LLC’s holdings in Option Care Health were worth $31,195,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. UMB Bank n.a. grew its stake in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after purchasing an additional 471 shares during the period. Lindenwold Advisors INC boosted its holdings in Option Care Health by 5.4% in the 3rd quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock valued at $299,000 after purchasing an additional 489 shares during the period. Pacer Advisors Inc. boosted its holdings in Option Care Health by 2.2% in the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock valued at $591,000 after purchasing an additional 537 shares during the period. Finally, Sheets Smith Wealth Management boosted its holdings in Option Care Health by 2.4% in the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock valued at $553,000 after purchasing an additional 550 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Stock Performance

NASDAQ OPCH opened at $31.46 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a market capitalization of $5.35 billion, a P/E ratio of 26.44, a P/E/G ratio of 2.19 and a beta of 1.35. The company has a fifty day moving average of $26.69 and a 200-day moving average of $27.93. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $34.63.

Analysts Set New Price Targets

OPCH has been the subject of several analyst reports. The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. UBS Group initiated coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target for the company. Truist Financial cut their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. Finally, Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and raised their price target for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $32.25.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.